Itron (NASDAQ:ITRI) SVP Donald Reeves III Sells 293 Shares

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Donald Reeves III sold 293 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $84.50, for a total transaction of $24,758.50. Following the completion of the sale, the senior vice president directly owned 28,807 shares in the company, valued at approximately $2,434,191.50. This represents a 1.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Itron Trading Down 2.0%

Shares of NASDAQ:ITRI opened at $83.59 on Friday. Itron, Inc. has a 52 week low of $77.77 and a 52 week high of $142.00. The company’s 50 day moving average is $87.89 and its two-hundred day moving average is $93.81. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. The company has a market cap of $3.71 billion, a PE ratio of 13.33, a P/E/G ratio of 0.75 and a beta of 1.35.

Itron (NASDAQ:ITRIGet Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.04 million. During the same period in the prior year, the firm posted $1.52 EPS. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Equities analysts predict that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ITRI has been the topic of a number of recent analyst reports. Robert W. Baird set a $128.00 target price on shares of Itron and gave the company an “outperform” rating in a research report on Wednesday, February 18th. JPMorgan Chase & Co. dropped their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Raymond James Financial initiated coverage on shares of Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating on the stock. Roth Mkm reaffirmed a “buy” rating and issued a $136.00 target price on shares of Itron in a research report on Wednesday, April 29th. Finally, TD Cowen dropped their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Read Our Latest Research Report on ITRI

Institutional Trading of Itron

Several hedge funds and other institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its holdings in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares in the last quarter. PFG Investments LLC grew its holdings in Itron by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock valued at $256,000 after purchasing an additional 94 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares in the last quarter. Xponance Inc. grew its holdings in Itron by 3.2% during the 3rd quarter. Xponance Inc. now owns 3,757 shares of the scientific and technical instruments company’s stock valued at $468,000 after purchasing an additional 115 shares in the last quarter. Finally, Impact Partnership Wealth LLC grew its holdings in Itron by 4.7% during the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company’s stock valued at $239,000 after purchasing an additional 119 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.